Structural and Clinical Predictors of Cognitive Impairment After Surgical Treatment for Ruptured Cerebral Aneurysms
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- University of Campinas, Brazil
- Azonosító
- NCT07723131
- A regiszteradat frissítve
- 2026. július 23.
- Eredeti leírás
This study investigates the clinical and structural predictors of long-term cognitive impairment in patients who underwent microsurgical clipping for aneurysmal subarachnoid hemorrhage. Using a retrospective cohort with prospective neuropsychological and MRI assessments, it aims to identify factors associated with late cognitive deficits and improve prognostic stratification, rehabilitation planning, and long-term patient care.A teljes eredeti leírásKevesebb
Structural and Clinical Predictors of Late Cognitive Impairment After Microsurgical Clipping of Ruptured Cerebral Aneurysms: A Retrospective Cohort With Prospective Assessment
This study investigates the clinical and structural predictors of long-term cognitive impairment in patients who underwent microsurgical clipping for aneurysmal subarachnoid hemorrhage. Using a retrospective cohort with prospective neuropsychological and MRI assessments, it aims to identify factors associated with late cognitive deficits and improve prognostic stratification, rehabilitation planning, and long-term patient care.
Bevonási feltételek: Age ≥18 years at the time of aSAH; Treatment by microsurgical clipping of a ruptured cerebral aneurysm; Survival until study recruitment; Ability to understand and sign informed consent.
Kizáró feltételek: Previous diagnosis of dementia; Non-aneurysmal subarachnoid hemorrhage; Severe neurological or psychiatric disorders unrelated to aSAH with significant cognitive impact; Exclusively endovascular treatment; Absolute contraindication to MRI; Severe aphasia preventing adequate neuropsychological evaluation; Incomplete clinical data; Inability to attend in-person assessment.